Heel Pain is the leading podiatric medical complaint
FREDERICK, MD, USA, October 23, 2013 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced today the completion of a randomized, placebo controlled crossover trial on plantar fasciitis (heel pain) using ActiPatch®. ActiPatch uses pulsed shortwave field therapy to reduce pain, inflammation and promote the healing of injured tissue.
The clinical study participants had on average, experienced chronic plantar fasciitis symptoms for close to 2.5 years. The two participant groups received both four (4) weeks of active therapy and then four (4) weeks of placebo treatment or vice versa. The study results showed strong improvement on a week by week basis, statistically above baseline at 4 weeks, 9 weeks and 26 weeks, with 26 weeks showing the most improvement for both pain and disability. Improvement at 26 weeks was the study primary end point and is indicative of tissue remodeling and healing. No adverse effects were reported. The study was conducted at the University of British Columbia and led by Professor Jack Taunton, Division of Sports Medicine, Faculty of Medicine.
The American Podiatric Medical Association reports that heel pain is the most prevalent medical condition being treated in podiatric clinics. Treatment options are limited, and currently there are no simple, low cost effective treatments available for sufferers of plantar fasciitis. ActiPatch® offers an excellent treatment alternative.
Note: Plantar fasciitis is now being referred to as plantar fasciopathy in sports medicine.
Other Clinical Research
BioElectronics is conducting a series of clinical research studies using its medical devices for musculoskeletal pain conditions including, osteoarthritis of the knee, acute nonspecific lower back pain, and postoperative recovery for 3rd molar extraction and hernia surgical repair. Details can be found at http://www.bielcorp.com/clinical-evidence/ along with details of previously completed and published clinical trials.
About BioElectronics Corporation
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, anti-inflammatory devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses. For more information, please visit www.bielcorp.com.